Vifor Pharma, a Swiss global specialty pharmaceutical company, has named Stefan Schulze as its new CEO effective 14 May 2020, it was reported on Thursday.
Presently, Schulze has been the president of the Executive Committee and chief operating officer since 2017.
Schulze, an engineer by education, spent his professional career in the healthcare industry in the United States and Europe. He was working for the Fresenius Group in various positions from 1992 to 2014. In 2014 he became CEO of Vifor Fresenius Medical Care Renal Pharma.
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits